207 related articles for article (PubMed ID: 31019097)
1. Leptomeningeal metastases in glioma: The Memorial Sloan Kettering Cancer Center experience.
Andersen BM; Miranda C; Hatzoglou V; DeAngelis LM; Miller AM
Neurology; 2019 May; 92(21):e2483-e2491. PubMed ID: 31019097
[TBL] [Abstract][Full Text] [Related]
2. Leptomeningeal dissemination in glioblastoma; an inspection of risk factors, treatment, and outcomes at a single institution.
Mandel JJ; Yust-Katz S; Cachia D; Wu J; Liu D; de Groot JF; Yung AW; Gilbert MR
J Neurooncol; 2014 Dec; 120(3):597-605. PubMed ID: 25168214
[TBL] [Abstract][Full Text] [Related]
3. Leptomeningeal disease from oligodendroglioma: clinical and molecular analysis.
Roldán G; Scott J; George D; Parney I; Easaw J; Cairncross G; Forsyth P; Yan E
Can J Neurol Sci; 2008 May; 35(2):204-9. PubMed ID: 18574935
[TBL] [Abstract][Full Text] [Related]
4. Leptomeningeal disease in pancreas ductal adenocarcinoma: A manifestation of longevity.
O'Connor CA; Park JS; Kaley T; Kezlarian B; Edelweiss M; Yang TJ; Park W; Reidy D; Varghese AM; Yu KH; O'Reilly EM
Pancreatology; 2021 Apr; 21(3):599-605. PubMed ID: 33582005
[TBL] [Abstract][Full Text] [Related]
5. Outcome of patients with pilocytic astrocytoma and leptomeningeal dissemination.
Mazloom A; Hodges JC; Teh BS; Chintagumpala M; Paulino AC
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):350-4. PubMed ID: 22401918
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and Outcomes of Patients With Breast Cancer With Leptomeningeal Metastasis.
Morikawa A; Jordan L; Rozner R; Patil S; Boire A; Pentsova E; Seidman AD
Clin Breast Cancer; 2017 Feb; 17(1):23-28. PubMed ID: 27569275
[TBL] [Abstract][Full Text] [Related]
7. Risk of leptomeningeal disease in patients treated with stereotactic radiosurgery targeting the postoperative resection cavity for brain metastases.
Atalar B; Modlin LA; Choi CY; Adler JR; Gibbs IC; Chang SD; Harsh GR; Li G; Nagpal S; Hanlon A; Soltys SG
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):713-8. PubMed ID: 24054875
[TBL] [Abstract][Full Text] [Related]
8. Leptomeningeal disease from melanoma-Poor prognosis despite new therapeutic modalities.
Chorti E; Kebir S; Ahmed MS; Keyvani K; Umutlu L; Kanaki T; Zaremba A; Reinboldt-Jockenhoefer F; Knispel S; Gratsias E; Roesch A; Ugurel S; Scheffler B; Schadendorf D; Livingstone E; Meier F; Glas M; Zimmer L
Eur J Cancer; 2021 May; 148():395-404. PubMed ID: 33789203
[TBL] [Abstract][Full Text] [Related]
9. Treatment and prognosis of leptomeningeal disease secondary to metastatic breast cancer: A single-centre experience.
Kingston B; Kayhanian H; Brooks C; Cox N; Chaabouni N; Redana S; Kalaitzaki E; Smith I; O'Brien M; Johnston S; Parton M; Noble J; Stanway S; Ring A; Turner N; Okines A
Breast; 2017 Dec; 36():54-59. PubMed ID: 28968585
[TBL] [Abstract][Full Text] [Related]
10. Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001.
Deorah S; Lynch CF; Sibenaller ZA; Ryken TC
Neurosurg Focus; 2006 Apr; 20(4):E1. PubMed ID: 16709014
[TBL] [Abstract][Full Text] [Related]
11. Posterior fossa metastases: risk of leptomeningeal disease when treated with stereotactic radiosurgery compared to surgery.
Siomin VE; Vogelbaum MA; Kanner AA; Lee SY; Suh JH; Barnett GH
J Neurooncol; 2004; 67(1-2):115-21. PubMed ID: 15072456
[TBL] [Abstract][Full Text] [Related]
12. Leptomeningeal dissemination of malignant gliomas. Incidence, diagnosis and outcome.
Arita N; Taneda M; Hayakawa T
Acta Neurochir (Wien); 1994; 126(2-4):84-92. PubMed ID: 8042560
[TBL] [Abstract][Full Text] [Related]
13. Leptomeningeal disease in glioblastoma: endgame or opportunity?
Akmal S; Ginalis EE; Patel NV; Aiken R; Dicpinigaitis AJ; Hanft SJ
J Neurooncol; 2021 Nov; 155(2):107-115. PubMed ID: 34623599
[TBL] [Abstract][Full Text] [Related]
14. Integrative radiogenomic analysis for genomic signatures in glioblastomas presenting leptomeningeal dissemination.
You HJ; Park HY; Kim J; Lee IH; Seol HJ; Lee JI; Kim ST; Kong DS; Nam DH
Medicine (Baltimore); 2016 Jul; 95(27):e4109. PubMed ID: 27399113
[TBL] [Abstract][Full Text] [Related]
15. Changing incidence and improved survival of gliomas.
Ho VK; Reijneveld JC; Enting RH; Bienfait HP; Robe P; Baumert BG; Visser O;
Eur J Cancer; 2014 Sep; 50(13):2309-18. PubMed ID: 24972545
[TBL] [Abstract][Full Text] [Related]
16. Hemorrhagic and Cystic Brain Metastases Are Associated With an Increased Risk of Leptomeningeal Dissemination After Surgical Resection and Adjuvant Stereotactic Radiosurgery.
Press RH; Zhang C; Chowdhary M; Prabhu RS; Ferris MJ; Xu KM; Olson JJ; Eaton BR; Shu HG; Curran WJ; Crocker IR; Patel KR
Neurosurgery; 2019 Nov; 85(5):632-641. PubMed ID: 30335175
[TBL] [Abstract][Full Text] [Related]
17. Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD).
Ferguson SD; Bindal S; Bassett RL; Haydu LE; McCutcheon IE; Heimberger AB; Li J; O'Brien BJ; Guha-Thakurta N; Tetzlaff MT; Tawbi H; Davies MA; Glitza IC
J Neurooncol; 2019 May; 142(3):499-509. PubMed ID: 30847840
[TBL] [Abstract][Full Text] [Related]
18. Intracranial dural metastases.
Nayak L; Abrey LE; Iwamoto FM
Cancer; 2009 May; 115(9):1947-53. PubMed ID: 19241421
[TBL] [Abstract][Full Text] [Related]
19. Intrathecal chemotherapy for leptomeningeal disease in high-grade gliomas: a systematic review.
Singh E; Gurses ME; Costello MC; Berke C; Lu VM; Daggubati L; Komotar RJ; Ivan ME; Shah AH
J Neurooncol; 2024 Mar; 167(1):39-47. PubMed ID: 38294637
[TBL] [Abstract][Full Text] [Related]
20. Surgical Resection of Brain Metastases and the Risk of Leptomeningeal Recurrence in Patients Treated With Stereotactic Radiosurgery.
Johnson MD; Avkshtol V; Baschnagel AM; Meyer K; Ye H; Grills IS; Chen PY; Maitz A; Olson RE; Pieper DR; Krauss DJ
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):537-43. PubMed ID: 26867883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
